Navidea Announces Restructuring of Pipeline Development
May 15, 2014 16:30 ET
|
Navidea Biopharmaceuticals
Dr. Michael Goldberg Appointed as Interim CEO
Dr. Mark Pykett to Head Up Manocept Programs
Conference Call Scheduled for Friday, May 16th at 8:30 am ET / 5:30 am PT
DUBLIN, Ohio, May 15, 2014...